Search results for "Highlights"


 
Results 151 - 160 of about 446 for "Highlights".
Sort by: Relevance | Newest | Oldest

SGLT-2 inhibitors associated with fewer serious renal events than DPP-4 inhibitors

In a propensity-matched Scandinavian study, new users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had a lower risk of renal replacement therapy and hospital admission for renal events than new users of dipeptidyl peptidase-4 (DPP-4) inhibitors.
https://diabetes.acponline.org/archives/2020/05/08/2.htm
8 May 2020

Patients with type 1 diabetes spending more on supplies than insulin

Mean out-of-pocket spending for all care among a national sample of insured patients with type 1 diabetes was nearly $2,500 in 2018, according to one study, while a second study found that commercially insured patients' out-of-pocket insulin costs have peaked.
https://diabetes.acponline.org/archives/2020/06/12/3.htm
12 Jun 2020

Review looks at metformin safety, effectiveness in patients with reduced renal function

Metformin appears to be associated with reduced mortality at estimated glomerular filtration rates as low as 45 mL/min/1.73 m2, but safety concerns arise with rates at or below 30 mL/min/1.73 m2.
https://diabetes.acponline.org/archives/2021/06/11/1.htm
11 Jun 2021

Diabetes-related variables, general comorbidities may predict major osteoporotic fractures

A study of African-American, Hispanic, and Caucasian patients with type 1 and type 2 diabetes found that the most significant predictors of fracture risk varied by race and ethnicity.
https://diabetes.acponline.org/archives/2020/04/10/2.htm
10 Apr 2020

Oral semaglutide led to greater reductions in HbA1c, body weight than sitagliptin

The industry-funded PIONEER 3 trial randomized adults whose type 2 diabetes was uncontrolled with metformin, with or without sulfonylurea, to receive either oral sitagliptin (100 mg/d) or oral semaglutide (3, 7, or 14 mg/d).
https://diabetes.acponline.org/archives/2019/04/05/2.htm
5 Apr 2019

SGLT-2 inhibitors reduced risk of cardiovascular disease, death, review finds

The authors of a systematic review and meta-analysis recommended reconsideration of guidelines on sodium-glucose cotransporter-2 (SGLT-2) inhibitors to increase use among patients at risk of cardiovascular disease.
https://diabetes.acponline.org/archives/2020/02/14/3.htm
14 Feb 2020

Type 2 diabetes, elevated glucose associated with increased risk of unspecified dementia

Risk of Alzheimer's disease or vascular dementia was not associated with nonfasting plasma glucose levels in a large Danish study that included patients with and without diabetes.
https://diabetes.acponline.org/archives/2020/04/10/3.htm
10 Apr 2020

HbA1c testing in barbershops identified black men with undiagnosed diabetes

About one-third of men approached in barbershops owned by black individuals were willing to be screened for diabetes, and 9% of them had undiagnosed diabetes while 28% had prediabetes.
https://diabetes.acponline.org/archives/2020/02/14/2.htm
14 Feb 2020

Spotlight on the effects of exercise in diabetes

Studies published in the past month looked at how exercise and indicators of fitness among patients with diabetes are associated with mortality risk, vascular health, and medication use.
https://diabetes.acponline.org/archives/2020/02/14/5.htm
14 Feb 2020

Meta-analysis quantifies survival gains from bariatric surgery

According to an analysis of studies of severely obese patients, metabolic-bariatric surgery was associated with median life expectancy gains of 9.3 years in patients with diabetes and 5.1 years in patients without diabetes.
https://diabetes.acponline.org/archives/2021/05/14/1.htm
14 May 2021

Result Page: Prev   11   12   13   14   15   16   17   18   19   20   Next